Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 21, 2014; 20(43): 15965-15974
Published online Nov 21, 2014. doi: 10.3748/wjg.v20.i43.15965
Table 1 End-points generally evaluated to assess treatment efficacy
RVRUndetectable serum hepatitis C virus (HCV) RNA after 4 wk of treatment
EVRUndetectable or at least a 2 log decrease in serum HCV RNA from baseline level after 12 wk of treatment
End-of-treatment responseUndetectable serum HCV RNA at the conclusion of treatment
SVRUndetectable serum HCV RNA 24 wk after the end of treatment
Non-responseDetectable serum HCV RNA at 24 wk of treatment without any significant decrease in serum HCV RNA level
RelapseDetection of serum HCV RNA after SVR had been achieved